CircuLite (Saddle Brook, NJ) a clinical-stage medical device company focused on minimally invasive implantable devices for chronic heart failure, closed a $30M Series D financing. Participants include Forbion Capital Partners and MacAndrews & Forbes Holdings.

Acutus Medical (San Diego, CA) a development-stage medical device company focused on electrophysiological mapping technology for the treatment of cardiac arrhythmias, closed a $1M Series A financing. Participants include Index Ventures.
Thanx for your patience as we catch-up.

Acutus Medical (San Diego, CA) a development-stage medical device company focused on electrophysiological mapping for the treatment of cardiac arrhythmias, closed a $1M Series A financing. Participants include Index Ventures.

Miracor Medical Systems (Austria) a development-stage medical device company focused on acute coronary syndrome and heart failure, closed a $10M Series B financing. Participants include Austria Wirtschaftsservice, SHS, Earlybird and Delta Partners.

CardioKinetix (Redwood City, CA) a clinical-stage medical device company focused on transcatheter implants for congestive heart failure, closed a $44M Series E financing. Participants include SV Life Sciences, New Leaf Venture Partners, U.S. Venture Partners, J.P. Morgan Partners, H&Q Healthcare Investors and H&Q Life Sciences Investors.

Jan Medical (Mountain View, CA) a development-stage medical device company focused on a brain sensing device for the timely determination of ischemic stroke, closed a $3.1M Series A financing. Participants include Brainlab.
The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science professionals [...]

Cameron Health (San Clemente, CA) a commercial-stage medical device company focused on a subcutaneous implantable defibrillator platform, closed a $107M Series E financing. Participants include Alloy Ventures and Delphi Ventures.

CardioDx (Palo Alto, CA) a commercial-stage cardiovascular molecular diagnostics company focused on coronary artery disease, cardiac arrhythmia and heart failure, closed a $60M Series E financing. Participants include Longitude Capital, J.P. Morgan, Acadia Woods Partners, Artian Ventures and Briht Capital.

Veniti (Saint Louis, MO) a development-stage medical device company focused on iliac vein outflow obstruction, closed a $13.5M Series A financing. Participants include Baird Venture Partners and H&Q Healthcare Investors.

BridgePoint Medical (Minneapolis, MN) a clinical-stage medical device company focused on interventional cardiology for access to and treatment of chronic total occlusions, closed a $9.1M Series C financing. Participants include New Enterprise Associates, Polaris Venture Partners and Foundation Medical Partners.

NeoGraft Technologies (Pittsburgh, PA) a development-stage medical device company focused on coronary artery disease, closed a $3M Series B financing. Participants were not identified.

Symetis (Switzerland) a clinical-stage medical device company focused on a transcatheter aortic valve implantation, closed a $25.8M Series C financing. Participants include Endeavour Vision, NBGI Ventures, Truffle Capital, Novartis Venture Fund, Wellington Partners Venture Capital, Vinci Capital, Renaissance PME, Banexi Venture Partners and BiomedInvest.

Tyrx (Monmouth Junction, NJ) a commercial-stage drug:device combo company focused on a dissolving antibacterial biocompatible mesh envelope to house implanted devices such as pacemakers and defibrillators, closed a $16M Series C financing. Participants include HLM Venture Partners, Clarus Ventures and Pappas Ventures.